References
- Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation 1972: 45(5): 991–1004
- Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: a cooperative study. JAMA 1977: 237(3): 255–61
- The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1980: 140(10): 1280–5
- The 1984 report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1984: 144(5): 1045–57
- The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988: 148(5): 1023–38
- Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in “mild” hypertension: results of the Hypertension Detection and Fbllow-Up Program, N Engl J Med 1982: 307(16): 976–80
- Tweedale M, Ogilvie R, Ruedy J. Antihypertensive and biochemical effects of chlorthalidone. Clin Pharmacol Ther 1977: 22(5): 519–27
- Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982: 248(12): 1465–77
- Smith WM. Treatment of mild hypertension: results of a ten-year intervention trial. Circ Res 1977: 40(5 Suppl 1): 198–105
- Report of Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981: 2(8246): 539–43
- Hulley SB, Furberg CD, Gurland B, et al. Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone. Am J Cardiol 1985: 56(15): 913–20
- Lasser NL, Grandits G, Caggiula AW. et al. Effects of antihypertensive therapy on plasma lipids and lipoproteins in the Multiple Risk Factor Intervention Trial. Am J Med 1984: 76(2A): 52–66
- Khan AH. Beta-adrenoreceptor blocking agents: their role in reducing chances of recurrent infarction and death. Arch Intern Med 1983: 143(9): 1759–62
- Buhler FR. Age and cardiovascular response adaptation: determinants of an antihypertensive treatment concept primarily based on beta-blockers and calcium entry blockers. Hypertension 1983: 5(5 Pt 2): III94–100
- Wikstrand J, Westergren G, Berglund G, et al. Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60 to 75 years: report from a double-blind international multicenter study. JAMA 1986: 255(10): 1304–10
- Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. JAMA 1982: 248(16): 1996–2003
- Weinberger MH. Comparison of Captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension. Br J Clin Pharmacol 1982: 14(Suppl 2): 127–31S
- Prince MJ, Stuart CA, Padia M, et al. Metabolic effects of hydrochlorothiazide and enalapril during treatment of the hypertensive diabetic patient: enalapril for hypertensive diabetics. Arch Intern Med 1988: 148(11): 2363–8
- The Multicenter Diltiazem Postinfarction Trial Research Group. The effect of dlltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988: 319(7): 385–92
- Cubeddu LX, Aranda J. Singh B, et al. A comparison of verapamil and propranolol for the initial treatment of hypertension: racial differences in response. JAMA 1986: 256(16): 2214–21